Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Mohammad Yaghoob"'
Autor:
Seyed Mohsen Mirabdolhosseini, Mohammad Yaghoob Taleghani, Leili Rejali, Hossein Sadeghi, Nayeralsadat Fatemi, Mehdi Tavallaei, Amin Famil Meyari, Narges Saeidi, Pardis Ketabi Moghadam, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Ehsan Nazemalhosseini Mojarad
Publikováno v:
Cancer Reports, Vol 7, Iss 1, Pp n/a-n/a (2024)
Abstract Background Approximately 5% of colorectal cancers (CRCs) are hereditary. Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), is the most common form of recognized hereditary CRC. Although Iran, as a developi
Externí odkaz:
https://doaj.org/article/a454974b56704bf9a1743d83cb433cff
Autor:
Pegah Larki, Ehsan Gharib, Mohammad Yaghoob Taleghani, Fatemeh Khorshidi, Ehsan Nazemalhosseini-Mojarad, Hamid Asadzadeh Aghdaei
Publikováno v:
Cell Journal, Vol 19, Iss supp1, Pp 113-117 (2017)
The detection of KRAS and BRAF mutations is a crucial step for the correct therapeutic approach and predicting the epidermal growth factor receptor (EGFR)-targeted therapy resistance of colorectal carcinomas. The concomitant KRAS and BRAF mutations o
Externí odkaz:
https://doaj.org/article/a4b4ba02eaee4fbfa4e5b2e85084c374
Autor:
Mahdi Montazer Haghighi, Mohammad Yaghoob Yaghoub Taleghani, Atena Irani Shemirani, Zahra Akbari, Mohsen Vahedi, Seyyed Reza Mohebi, Seyyed Reza Fatemi, Arash Jenabian, Mohammadreza Zali
Publikováno v:
پزشکی بالینی ابن سینا, Vol 18, Iss 2, Pp 45-49 (2011)
Introduction & Objective: One candidate gene for colorectal cancer susceptibility is exonuclease1 (EXO1) .It is a member of RAD2 nuclease family. It plays a main role in mismatch repair. EXO1 acts also in DNA replication and recombination. Single nuc
Externí odkaz:
https://doaj.org/article/c825d6d8b84241ccb8c39ca20384a6c3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Asri, Nastaran, Mojarad, Ehsan Nazemalhosseini, Taleghani, Mohammad Yaghoob, Houri, Hamidreza, Niasar, Mahsa Saeedi, Rezaei-Tavirani, Mostafa, Jahani-Sherafat, Somayeh, Shahbazkhani, Amirhossein, Nikzamir, Abdolrahim, Ardakani, Mohammad Javad Ehsani, Khodadost, Mahmood, Rostami-Nejad, Mohammad
Publikováno v:
Asian Pacific Journal of Cancer Prevention; Feb2024, Vol. 25 Issue 2, p647-652, 6p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mirabdolhosseini, Seyed Mohsen, Rejali, Leili, Taleghani, Mohammad Yaghoob, Sadeghi, Hossein, Hossein Kashfi, Seyed Mohammad, Farahbakhsh, Faeghe Behboudi, Golmohammadi, Mina, Larki, Pegah, Fatemi, Nayeralsadat, Moghadam, Pardis Ketabi, Mojarad, Ehsan Nazemalhosseini, Sadeghi, Amir, Aghdaie, Hamid Asadzadeh, Zali, Mohammad Reza
Publikováno v:
Nucleosides, Nucleotides & Nucleic Acids; 2024, Vol. 43 Issue 1, p40-56, 17p
Autor:
Khanabadi, Binazir, Seyfi, Diba Najafgholizadeh, Rejali, Leili, Taleghani, Mohammad Yaghoob, Tavallaei, Mehdi, Shahrokh, Shabnam, Abkenar, Elahe Daskar, Noukabadi, Fatemeh Naderi, Aghdaei, Hamid Asadzadeh, Mojarad, Ehsan Nazemalhosseini
Publikováno v:
Gastroenterology & Hepatology from Bed to Bench; Summer2023, Vol. 16 Issue 3, p341-346, 6p
Autor:
Hamid Asadzadeh Aghdaei, Mohmad Amin Pourhoseingholi, Mohammad Reza Zali, Sara Ashtari, Kaveh Baghaei, Mohammad Yaghoob Taleghani, Ehsan Nazemalhosseini-Mojarad, Noshad Peyravian, Mina Golmohammadi, Maryam Mehrizi, Roya Kishani Farahani
Publikováno v:
Journal of Gastrointestinal Cancer. 51:53-62
To evaluate the prognostic role of BRAF and KRAS mutations after adjustment for microsatellite instability (MSI) in Iranian colorectal cancer (CRC) patients. BRAF and KRAS mutations and MSI status were assessed in 258 Iranian subjects with CRC. Two h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d20af578b9d617b480af360a40a9eb
https://doi.org/10.1007/s12029-019-00201-4
https://doi.org/10.1007/s12029-019-00201-4
Autor:
Hamid Asadzadeh Aghdaei, Mona Malekzade-Moghani, Parinaz Nasri Nasrabadi, Mohammad Reza Zali, Mohammad Amin Meiary, Reza Salmanipour, Ehsan Gharib, Mohammad Yaghoob Taleghani, Saharnaz Sarlak, Ehsan Nazemalhosseini Mojarad
Publikováno v:
Journal of Cellular Physiology. 234:13137-13144
The human epidermal growth factor 2 (HER2) gene undergoes various mutations that could alter its activity or respond to the antibody therapies. Cetuximab, a known anti-EGFR monoclonal antibody (mAB), is widely administered in metastatic colorectal ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8c040f0337582fa17a7ed8721b0a7b8
https://doi.org/10.1002/jcp.27984
https://doi.org/10.1002/jcp.27984